Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)â€...
India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Oze...
Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...
Germany-based medisana, a trusted global brand in home health and wellness solutions, has announced a strategic partners...
Glutamate-Glutamate-Methionine-Glutamine-Arginine-Arginine-Alanine-Aspartate-NHâ‚‚, has emerged as a notable synthetic p...
South Korea-based GCCL Co., a data-driven clinical trial services provider, and Germany-based Medicover Integrated Clini...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex...
China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...
South Korea-based startup Sky Labs Inc. has entered into an exclusive distribution agreement with Otsuka Pharmaceut...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Dete...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics, a South Korea-based contract ...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the termination of the current rocatin...
South Korea-based SK bioscience will advance a novel respiratory syncytial virus (RSV) monoclonal antibody (mAb) for glo...
Australia-based startup AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha the...
Cambridge Health Group, the GCC's leading provider of post-acute care, has renewed its long-standing partnership with th...
Frontage Laboratories, Inc., a global Contract Research, Development and Manufacturing Organization (CRDMO), has announc...
DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of ...
SBC Medical Group Holdings Incorporated, a global provider of comprehensive consulting and management services to medica...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
China-based Baird Medical Investment Holdings, a market leader in minimally invasive Microwave Ablation (MWA) technology...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a breakthrough Continuou...
Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 c...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Palo Alto‑based PGxAI, a leader in AI-powered pharmacogenomics, and Saudi Arabia’s Novo Genomics ...
Japan-based companies Otsuka Pharmaceutical Co. and Towa Pharmaceutical Co. have entered into an agreement to establish ...
South Korea-based SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vaccine under a...
Singapore based HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced ...
MS Pharma Group, a leading regional pharmaceutical company in the Middle East and North Africa (MENA) region, has signed...
Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary soluti...
Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening ...
GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...
US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to ...
Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...
Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...
US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...
Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy ...
US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer trea...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
Japanese pharmaceutical firm Takeda has announced a global collaboration and license agreement with US-based Halozyme Th...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
SK bioscience has announced the new domestic launch of MenQuadfi Injection (MenQuadfi, MenACWY-TT), a quadrivalent menin...
Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...
Taiwan-based Foresee Pharmaceuticals has announced that Foresee Pharmaceuticals USA Inc., the company's fully-owned US s...
South Korea based startup Sky Labs has announced that its ring-type blood pressure monitor, 'CART PLATFORM,' recent...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulti...
US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...
Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana® I.V. Infusion 60...
Singapore-based Hyphens Pharma International has granted the rights to commercialise its innovative product, Cerapro®...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
ScinoPharm Taiwan has announced a landmark achievement in the global pharmaceutical landscape, securing US Food and Drug...
Japan's Shionogi & Co. will acquire a newly established company that Tanabe Pharma Corporation will create to hold t...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
China-based Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has announce...
South Korea-based KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global ...
How would KBI Biopharma highlight its achievements in 2025? Which key projects strengthened the company’s global C...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...
Fujifilm Corporation has announced the completion of one of Japan’s largest bio CDMO facilities (the new plan...
French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...
AeviceMD Monitoring System, a non-invasive wearable respiratory monitoring solution developed by Singapore-based Aevice ...
Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture ...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
US-based Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the fi...
Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Galux, a South Korean biotech startup pioneering AI-driven protein therapeutics discovery, has signed a research agreeme...
MEDI&GENE, a South Korea-based biopharmaceutical company developing therapeutics for metabolic diseases, has entered...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
Germany-based numares Health, the transformative metabolomics company pioneering multidimensional biomarker insights tha...
Germany-based Merz Aesthetics, the world’s largest dedicated medical aesthetics business, has launched flagship pr...
ADEL, Inc., a South Korea-based biopharmaceutical company dedicated to developing therapies for neurodegenerative diseas...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
US-based ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer's disease and related dementias...
Rhinocare Korea, a medtech innovator specialising in drug-free respiratory care, has announced plans to establish a join...
What were the key highlights at Sygnature Discovery in 2025? Please elaborate upon the company's plans for 2026. Despit...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
Pillar Biosciences and AstraZeneca have announced an expansion of their existing laboratory access programme for NG...
Australia-based Immutep Limited and Dr. Reddy’s Laboratories, based in India, have announced that their ...
Leading European biopharmaceutical company, Menarini Asia-Pacific, has announced the expansion of its export manufacturi...
Australia’s onshore vaccine manufacturing capabilities took a leap forward as Mark Butler MP, Minister for Health,...
South Korea-based Samsung Bioepis Co. has announced the launch of OBODENCE™ (60 mg pre-filled syringe) a...
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced the grand opening of its new state-of-the-...
Japan's Fujitsu Limited has announced the development of a multi-AI agent collaboration technology that enable...
SAI Parenterals Limited (SPL), an India-based pharmaceutical formulation company, has announced the acquisition of a 74....
Singapore-based startup Patronus Biotech has announced a grant from the Gates Foundation to accelerate the development o...
According to reports, the APAC MedTech market is valued at $16.3 billion in 2025, with a potential to reach $18.6 billio...
2025 was the year when China’s stratospheric rise on the global biotech stage continued. According to a report fro...
SK Biopharmaceuticals, a South Korea-based biotech company specialising in research, development, and commercialisation ...
The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spin...
Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has signed an exclusive licensing agreement wi...
